Barbara Winograd
Psychiatry · Metuchen, NJNPI 1750442216
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,425 of the $14,192 with a category attached, or 66.4%. AbbVie accounts for 72.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $8,322 and has fallen 98.9% since, to $90 in 2023. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 378 payments — averaging $37.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Sunovion Pharmaceuticals Inc.$535
- Otsuka America Pharmaceutical, Inc.$530
- Neos Therapeutics, LP$444
- Validus Pharmaceuticals LLC$369
- Lundbeck LLC$306
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$9,42566%
- Food & beverage$4,76734%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $10,332 |
| Sunovion Pharmaceuticals Inc. | 33 | $535 |
| Otsuka America Pharmaceutical, Inc. | 51 | $530 |
| Neos Therapeutics, LP | 46 | $444 |
| Validus Pharmaceuticals LLC | 16 | $369 |
| Lundbeck LLC | 24 | $306 |
| Vanda Pharmaceuticals Inc. | 21 | $254 |
| Neurocrine Biosciences, Inc. | 12 | $248 |
| Bausch Health US, LLC | 15 | $200 |
| Johnson & Johnson | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $143 |
| Rhodes Pharmaceuticals L.p. | 11 | $138 |
| Avanir Pharmaceuticals, Inc. | 11 | $137 |
| Teva Pharmaceuticals USA, Inc. | 7 | $104 |
| Jazz Pharmaceuticals Inc. | 4 | $55 |
| Shire North American Group Inc | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Eisai Inc. | 2 | $28 |
| Pfizer | 2 | $27 |
| Vertical Pharmaceuticals, LLC | 2 | $26 |
| Corium, LLC | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Neuronetics, Inc. | 1 | $14 |
| Alkermes, Inc. | 1 | $13 |
| Almatica Pharma LLC | 1 | $13 |
| Harmony Biosciences LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,192 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Metuchen
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
- Boris BorodulinEast Brunswick$116K
- Anthony RostainCamden$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.